世界のmRNAワクチン＆治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global mRNA Vaccine And Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4530
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、109ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、mRNAワクチン＆治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（感染症、がん、その他）、用途別市場規模（病院、研究所）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・mRNAワクチン＆治療薬の市場動向
・企業の競争状況、市場シェア
・mRNAワクチン＆治療薬の種類別市場規模と予測2016-2027（感染症、がん、その他）
・mRNAワクチン＆治療薬の用途別市場規模と予測2016-2027（病院、研究所）
・mRNAワクチン＆治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・mRNAワクチン＆治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・mRNAワクチン＆治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・mRNAワクチン＆治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・mRNAワクチン＆治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Argos Therapeutics、BioNTech、CureVac、eTheRNA、Ethris、In-Cell-Art、Moderna Therapeutics、Sangamo Therapeutics、Tiba Biotechnology、Translate Bio）
・結論

mRNA vaccine is the drugs prepared using advanced technologies using mRNA as the genetic material. mRNA vaccines are a more efficient alternative owing to their enhanced immunogenicity, higher potency, rapid development, relatively cheaper and safer over conventional vaccines.

Market Analysis and Insights: Global mRNA Vaccine And Therapeutics Market
The global mRNA Vaccine And Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global mRNA Vaccine And Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global mRNA Vaccine And Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global mRNA Vaccine And Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global mRNA Vaccine And Therapeutics market.

Global mRNA Vaccine And Therapeutics Scope and Market Size
mRNA Vaccine And Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global mRNA Vaccine And Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Infectious Disease
Cancer
Others

Segment by Application
Hospital
Research Institual

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Argos Therapeutics
BioNTech
CureVac
eTheRNA
Ethris
In-Cell-Art
Moderna Therapeutics
Sangamo Therapeutics
Tiba Biotechnology
Translate Bio

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Vaccine And Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Infectious Disease
1.2.3 Cancer
1.2.4 Others
1.3 Market by Application
1.3.1 Global mRNA Vaccine And Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Research Institual
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global mRNA Vaccine And Therapeutics Market Perspective (2016-2027)
2.2 mRNA Vaccine And Therapeutics Growth Trends by Regions
2.2.1 mRNA Vaccine And Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 mRNA Vaccine And Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 mRNA Vaccine And Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 mRNA Vaccine And Therapeutics Industry Dynamic
2.3.1 mRNA Vaccine And Therapeutics Market Trends
2.3.2 mRNA Vaccine And Therapeutics Market Drivers
2.3.3 mRNA Vaccine And Therapeutics Market Challenges
2.3.4 mRNA Vaccine And Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top mRNA Vaccine And Therapeutics Players by Revenue
3.1.1 Global Top mRNA Vaccine And Therapeutics Players by Revenue (2016-2021)
3.1.2 Global mRNA Vaccine And Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global mRNA Vaccine And Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by mRNA Vaccine And Therapeutics Revenue
3.4 Global mRNA Vaccine And Therapeutics Market Concentration Ratio
3.4.1 Global mRNA Vaccine And Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Vaccine And Therapeutics Revenue in 2020
3.5 mRNA Vaccine And Therapeutics Key Players Head office and Area Served
3.6 Key Players mRNA Vaccine And Therapeutics Product Solution and Service
3.7 Date of Enter into mRNA Vaccine And Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 mRNA Vaccine And Therapeutics Breakdown Data by Type
4.1 Global mRNA Vaccine And Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global mRNA Vaccine And Therapeutics Forecasted Market Size by Type (2022-2027)

5 mRNA Vaccine And Therapeutics Breakdown Data by Application
5.1 Global mRNA Vaccine And Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global mRNA Vaccine And Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America mRNA Vaccine And Therapeutics Market Size (2016-2027)
6.2 North America mRNA Vaccine And Therapeutics Market Size by Type
6.2.1 North America mRNA Vaccine And Therapeutics Market Size by Type (2016-2021)
6.2.2 North America mRNA Vaccine And Therapeutics Market Size by Type (2022-2027)
6.2.3 North America mRNA Vaccine And Therapeutics Market Size by Type (2016-2027)
6.3 North America mRNA Vaccine And Therapeutics Market Size by Application
6.3.1 North America mRNA Vaccine And Therapeutics Market Size by Application (2016-2021)
6.3.2 North America mRNA Vaccine And Therapeutics Market Size by Application (2022-2027)
6.3.3 North America mRNA Vaccine And Therapeutics Market Size by Application (2016-2027)
6.4 North America mRNA Vaccine And Therapeutics Market Size by Country
6.4.1 North America mRNA Vaccine And Therapeutics Market Size by Country (2016-2021)
6.4.2 North America mRNA Vaccine And Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe mRNA Vaccine And Therapeutics Market Size (2016-2027)
7.2 Europe mRNA Vaccine And Therapeutics Market Size by Type
7.2.1 Europe mRNA Vaccine And Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe mRNA Vaccine And Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe mRNA Vaccine And Therapeutics Market Size by Type (2016-2027)
7.3 Europe mRNA Vaccine And Therapeutics Market Size by Application
7.3.1 Europe mRNA Vaccine And Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe mRNA Vaccine And Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe mRNA Vaccine And Therapeutics Market Size by Application (2016-2027)
7.4 Europe mRNA Vaccine And Therapeutics Market Size by Country
7.4.1 Europe mRNA Vaccine And Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe mRNA Vaccine And Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific mRNA Vaccine And Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Type
8.2.1 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Application
8.3.1 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Region
8.4.1 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America mRNA Vaccine And Therapeutics Market Size (2016-2027)
9.2 Latin America mRNA Vaccine And Therapeutics Market Size by Type
9.2.1 Latin America mRNA Vaccine And Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America mRNA Vaccine And Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America mRNA Vaccine And Therapeutics Market Size by Type (2016-2027)
9.3 Latin America mRNA Vaccine And Therapeutics Market Size by Application
9.3.1 Latin America mRNA Vaccine And Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America mRNA Vaccine And Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America mRNA Vaccine And Therapeutics Market Size by Application (2016-2027)
9.4 Latin America mRNA Vaccine And Therapeutics Market Size by Country
9.4.1 Latin America mRNA Vaccine And Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America mRNA Vaccine And Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa mRNA Vaccine And Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Type
10.2.1 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Application
10.3.1 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Country
10.4.1 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Argos Therapeutics
11.1.1 Argos Therapeutics Company Details
11.1.2 Argos Therapeutics Business Overview
11.1.3 Argos Therapeutics mRNA Vaccine And Therapeutics Introduction
11.1.4 Argos Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2016-2021)
11.1.5 Argos Therapeutics Recent Development
11.2 BioNTech
11.2.1 BioNTech Company Details
11.2.2 BioNTech Business Overview
11.2.3 BioNTech mRNA Vaccine And Therapeutics Introduction
11.2.4 BioNTech Revenue in mRNA Vaccine And Therapeutics Business (2016-2021)
11.2.5 BioNTech Recent Development
11.3 CureVac
11.3.1 CureVac Company Details
11.3.2 CureVac Business Overview
11.3.3 CureVac mRNA Vaccine And Therapeutics Introduction
11.3.4 CureVac Revenue in mRNA Vaccine And Therapeutics Business (2016-2021)
11.3.5 CureVac Recent Development
11.4 eTheRNA
11.4.1 eTheRNA Company Details
11.4.2 eTheRNA Business Overview
11.4.3 eTheRNA mRNA Vaccine And Therapeutics Introduction
11.4.4 eTheRNA Revenue in mRNA Vaccine And Therapeutics Business (2016-2021)
11.4.5 eTheRNA Recent Development
11.5 Ethris
11.5.1 Ethris Company Details
11.5.2 Ethris Business Overview
11.5.3 Ethris mRNA Vaccine And Therapeutics Introduction
11.5.4 Ethris Revenue in mRNA Vaccine And Therapeutics Business (2016-2021)
11.5.5 Ethris Recent Development
11.6 In-Cell-Art
11.6.1 In-Cell-Art Company Details
11.6.2 In-Cell-Art Business Overview
11.6.3 In-Cell-Art mRNA Vaccine And Therapeutics Introduction
11.6.4 In-Cell-Art Revenue in mRNA Vaccine And Therapeutics Business (2016-2021)
11.6.5 In-Cell-Art Recent Development
11.7 Moderna Therapeutics
11.7.1 Moderna Therapeutics Company Details
11.7.2 Moderna Therapeutics Business Overview
11.7.3 Moderna Therapeutics mRNA Vaccine And Therapeutics Introduction
11.7.4 Moderna Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2016-2021)
11.7.5 Moderna Therapeutics Recent Development
11.8 Sangamo Therapeutics
11.8.1 Sangamo Therapeutics Company Details
11.8.2 Sangamo Therapeutics Business Overview
11.8.3 Sangamo Therapeutics mRNA Vaccine And Therapeutics Introduction
11.8.4 Sangamo Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2016-2021)
11.8.5 Sangamo Therapeutics Recent Development
11.9 Tiba Biotechnology
11.9.1 Tiba Biotechnology Company Details
11.9.2 Tiba Biotechnology Business Overview
11.9.3 Tiba Biotechnology mRNA Vaccine And Therapeutics Introduction
11.9.4 Tiba Biotechnology Revenue in mRNA Vaccine And Therapeutics Business (2016-2021)
11.9.5 Tiba Biotechnology Recent Development
11.10 Translate Bio
11.10.1 Translate Bio Company Details
11.10.2 Translate Bio Business Overview
11.10.3 Translate Bio mRNA Vaccine And Therapeutics Introduction
11.10.4 Translate Bio Revenue in mRNA Vaccine And Therapeutics Business (2016-2021)
11.10.5 Translate Bio Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global mRNA Vaccine And Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Infectious Disease
Table 3. Key Players of Cancer
Table 4. Key Players of Others
Table 5. Global mRNA Vaccine And Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global mRNA Vaccine And Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global mRNA Vaccine And Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global mRNA Vaccine And Therapeutics Market Share by Regions (2016-2021)
Table 9. Global mRNA Vaccine And Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global mRNA Vaccine And Therapeutics Market Share by Regions (2022-2027)
Table 11. mRNA Vaccine And Therapeutics Market Trends
Table 12. mRNA Vaccine And Therapeutics Market Drivers
Table 13. mRNA Vaccine And Therapeutics Market Challenges
Table 14. mRNA Vaccine And Therapeutics Market Restraints
Table 15. Global mRNA Vaccine And Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global mRNA Vaccine And Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top mRNA Vaccine And Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Vaccine And Therapeutics as of 2020)
Table 18. Ranking of Global Top mRNA Vaccine And Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by mRNA Vaccine And Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players mRNA Vaccine And Therapeutics Product Solution and Service
Table 22. Date of Enter into mRNA Vaccine And Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global mRNA Vaccine And Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global mRNA Vaccine And Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global mRNA Vaccine And Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global mRNA Vaccine And Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global mRNA Vaccine And Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global mRNA Vaccine And Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global mRNA Vaccine And Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global mRNA Vaccine And Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America mRNA Vaccine And Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America mRNA Vaccine And Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America mRNA Vaccine And Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America mRNA Vaccine And Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America mRNA Vaccine And Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America mRNA Vaccine And Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe mRNA Vaccine And Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe mRNA Vaccine And Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe mRNA Vaccine And Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe mRNA Vaccine And Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe mRNA Vaccine And Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe mRNA Vaccine And Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America mRNA Vaccine And Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America mRNA Vaccine And Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America mRNA Vaccine And Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America mRNA Vaccine And Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America mRNA Vaccine And Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America mRNA Vaccine And Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Argos Therapeutics Company Details
Table 63. Argos Therapeutics Business Overview
Table 64. Argos Therapeutics mRNA Vaccine And Therapeutics Product
Table 65. Argos Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Argos Therapeutics Recent Development
Table 67. BioNTech Company Details
Table 68. BioNTech Business Overview
Table 69. BioNTech mRNA Vaccine And Therapeutics Product
Table 70. BioNTech Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) & (US$ Million)
Table 71. BioNTech Recent Development
Table 72. CureVac Company Details
Table 73. CureVac Business Overview
Table 74. CureVac mRNA Vaccine And Therapeutics Product
Table 75. CureVac Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) & (US$ Million)
Table 76. CureVac Recent Development
Table 77. eTheRNA Company Details
Table 78. eTheRNA Business Overview
Table 79. eTheRNA mRNA Vaccine And Therapeutics Product
Table 80. eTheRNA Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) & (US$ Million)
Table 81. eTheRNA Recent Development
Table 82. Ethris Company Details
Table 83. Ethris Business Overview
Table 84. Ethris mRNA Vaccine And Therapeutics Product
Table 85. Ethris Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Ethris Recent Development
Table 87. In-Cell-Art Company Details
Table 88. In-Cell-Art Business Overview
Table 89. In-Cell-Art mRNA Vaccine And Therapeutics Product
Table 90. In-Cell-Art Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) & (US$ Million)
Table 91. In-Cell-Art Recent Development
Table 92. Moderna Therapeutics Company Details
Table 93. Moderna Therapeutics Business Overview
Table 94. Moderna Therapeutics mRNA Vaccine And Therapeutics Product
Table 95. Moderna Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Moderna Therapeutics Recent Development
Table 97. Sangamo Therapeutics Company Details
Table 98. Sangamo Therapeutics Business Overview
Table 99. Sangamo Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Sangamo Therapeutics Recent Development
Table 101. Tiba Biotechnology Company Details
Table 102. Tiba Biotechnology Business Overview
Table 103. Tiba Biotechnology mRNA Vaccine And Therapeutics Product
Table 104. Tiba Biotechnology Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Tiba Biotechnology Recent Development
Table 106. Translate Bio Company Details
Table 107. Translate Bio Business Overview
Table 108. Translate Bio mRNA Vaccine And Therapeutics Product
Table 109. Translate Bio Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) & (US$ Million)
Table 110. Translate Bio Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global mRNA Vaccine And Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Infectious Disease Features
Figure 3. Cancer Features
Figure 4. Others Features
Figure 5. Global mRNA Vaccine And Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Research Institual Case Studies
Figure 8. mRNA Vaccine And Therapeutics Report Years Considered
Figure 9. Global mRNA Vaccine And Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global mRNA Vaccine And Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global mRNA Vaccine And Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global mRNA Vaccine And Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global mRNA Vaccine And Therapeutics Market Share by Players in 2020
Figure 14. Global Top mRNA Vaccine And Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Vaccine And Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by mRNA Vaccine And Therapeutics Revenue in 2020
Figure 16. Global mRNA Vaccine And Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global mRNA Vaccine And Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America mRNA Vaccine And Therapeutics Market Share by Type (2016-2027)
Figure 20. North America mRNA Vaccine And Therapeutics Market Share by Application (2016-2027)
Figure 21. North America mRNA Vaccine And Therapeutics Market Share by Country (2016-2027)
Figure 22. United States mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe mRNA Vaccine And Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe mRNA Vaccine And Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe mRNA Vaccine And Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific mRNA Vaccine And Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific mRNA Vaccine And Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific mRNA Vaccine And Therapeutics Market Share by Region (2016-2027)
Figure 38. China mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America mRNA Vaccine And Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America mRNA Vaccine And Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America mRNA Vaccine And Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa mRNA Vaccine And Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa mRNA Vaccine And Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa mRNA Vaccine And Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Argos Therapeutics Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2016-2021)
Figure 58. BioNTech Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2016-2021)
Figure 59. CureVac Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2016-2021)
Figure 60. eTheRNA Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2016-2021)
Figure 61. Ethris Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2016-2021)
Figure 62. In-Cell-Art Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2016-2021)
Figure 63. Moderna Therapeutics Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2016-2021)
Figure 64. Sangamo Therapeutics Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2016-2021)
Figure 65. Tiba Biotechnology Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2016-2021)
Figure 66. Translate Bio Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5991 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、呼吸器合胞体ウイルス（RSV）治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（パリビズマブ、リバビリン、その他）、用途別市場規模（病院薬局、ドラッグストア、小売薬局、その他）、主要地域別市場規模...

世界の黒色腫診断＆治療薬市場規模・現状・予測（2021年-2027年）

Global Melanoma Diagnostics and Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4487 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、黒色腫診断＆治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（結節型黒色腫、表在性黒色腫、無色素性黒色腫、その他）、用途別市場規模（病院、診断センター、医療機関、その他）、主要地域別市場規模（北米...

世界のヒト免疫不全ウイルス (HIV) 治療薬市場規模・現状・予測（2021年-2027年）

Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5787 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、ヒト免疫不全ウイルス (HIV) 治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（NRTI、NNRTI、侵入＆融合阻害剤、プロテアーゼ阻害剤、インテグラーゼ阻害剤、補助受容体拮抗剤）、用途別市場...

世界の重症急性呼吸器症候群（SARS）治療薬市場規模・現状・予測（2021年-2027年）

Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4854 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、重症急性呼吸器症候群（SARS）治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CEL-1000、D-3252、FDX-000、INO-4500、LCA-60、その他）、用途別市場規模（病院、ク...

世界の低分子干渉RNA（siRNA）治療薬市場規模・現状・予測（2021年-2027年）

Global Small Interfering RNA (siRNA) Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4874 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、低分子干渉RNA（siRNA）治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（リポソームベース全身療法、ナノ粒子ベース全身療法、その他）、用途別市場規模（病院、研究機関、製薬・バイオテクノロジー...

世界の多嚢胞性卵巣症候群（PCOS）治療薬市場規模・現状・予測（2021年-2027年）

Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4731 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、多嚢胞性卵巣症候群（PCOS）治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口避妊薬、排卵誘発剤、顔面発毛阻害剤、インスリン感作剤）、用途別市場規模（病院、クリニック、その他）、主要地域別市...

世界のデュシェンヌ型筋ジストロフィー(DMD)治療薬市場規模・現状・予測（2021年-2027年）

Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size, Status and Forecast 2021-2027
QFJ1-5718 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、デュシェンヌ型筋ジストロフィー(DMD)治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エテプリルセン、デフラザコート、アタルレン）、用途別市場規模（病院、診療所、ホームケア）、主要地域別市場規...

世界のmRNAシーケンシング市場規模・現状・予測（2021年-2027年）

Global mRNA Sequencing Market Size, Status and Forecast 2021-2027
QFJ1-5869 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、mRNAシーケンシングの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、マイクロアレイ、シーケンシング）、用途別市場規模（製薬・バイオテクノロジー、学術研究・政府機関、病院・診断センター）、主要...

世界のネオアンチゲン癌ワクチン市場規模・現状・予測（2021年-2027年）

Global Neoantigen Cancer Vaccine Market Size, Status and Forecast 2021-2027
QFJ1-4561 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、ネオアンチゲン癌ワクチンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（個人特定ワクチン、既製ネオワクチン）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の樹状細胞癌ワクチン免疫療法市場規模・現状・予測（2021年-2027年）

Global Dendritic Cell Cancer Vaccine Immunotherapy Market Size, Status and Forecast 2021-2027
QFJ1-5694 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、樹状細胞癌ワクチン免疫療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（プロベンジ、アプセデン、CreaVax、その他）、用途別市場規模（小児科、成人用）、主要地域別市場規模（北米、アメリカ、欧州、...

世界のネオアンチゲン癌ワクチン市場規模・現状・予測（2021年-2027年） It is through the use of tumor cell-associated antigens to awaken the body's immune system against cancer. Market Analysis and Insights: Global Neoantigen Cancer Vaccine Market The global Neoantigen Cancer Vaccine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020,…
世界の樹状細胞癌ワクチン免疫療法市場規模・現状・予測（2021年-2027年） Dendritic cells (DCs) are one of the major antigen-presenting cells found in lymphoid organs. Main function of the dendritic cells is antigen display and activation of T-cells. Antigen display presents the identity of pathogen to T-cells for their identification and elimination from the body. These …
世界のmRNAシーケンシング市場規模・現状・予測（2021年-2027年） mRNA sequencing (mRNA-Seq) has rapidly become the method of choice for analyzing the transcriptomes of disease states, of biological processes, and across a wide range of study designs. In addition to being a highly sensitive and accurate means of quantifying gene expression, mRNA-Seq can identify b…
mRNAシーケンスのグローバル市場：規模・現状・予測2019-2025 mRNA sequencing (mRNA-Seq) has rapidly become the method of choice for analyzing the transcriptomes of disease states, of biological processes, and across a wide range of study designs. In addition to being a highly sensitive and accurate means of quantifying gene expression, mRNA-Seq can identify b…
mRNAシーケンスのグローバル市場：規模・現状・予測2019-2025 mRNA sequencing (mRNA-Seq) has rapidly become the method of choice for analyzing the transcriptomes of disease states, of biological processes, and across a wide range of study designs. In addition to being a highly sensitive and accurate means of quantifying gene expression, mRNA-Seq can identify b…